№ lp_1_2_10128
File format: docx
Character count: 16647
File size: 105 KB
Clinical procedure document detailing standardized methods for measuring patient blood glucose and ketone levels at the point of care, including equipment use, quality control, staff responsibilities, and documentation requirements.
Year:
2026
Region / City:
Canberra, Australia
Subject:
Blood glucose and ketone point-of-care testing
Document Type:
Procedure
Organization:
Canberra Health Services (CHS)
Intended Users:
Medical Officers, Nurses and Midwives, Allied Health Professionals, Students under supervision
Equipment:
Nova Statstrip XpressTM meter
Scope:
Inpatient facilities and community services of CHS Network
Compliance:
Internal Quality Control, External Quality Assurance Programme (EQAP)
Safety Measures:
Standard precautions and infection control procedures
Record Keeping:
Quality Control Logbook, EQAP reports retention
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Department:
University of Georgia, Environmental Safety Division
Date SOP was written:
Not specified
Date SOP was approved by PI/lab supervisor:
Not specified
Principal Investigator:
Not specified
Internal Lab Safety Coordinator/Lab Manager:
Not specified
Lab Phone:
Not specified
Office Phone:
Not specified
Emergency Contact:
Not specified
Type of SOP:
Hazardous Chemical
CAS Number:
90-94-8
Chemical Class:
Toxic, irritant, carcinogen
Physical Form:
Solid, light blue
Molecular Formula:
C17H20N2O
Boiling Point:
>360 °C
Protective Measures:
Respiratory, hand, eye, skin protection specified
Emergency Procedures:
Chemical spill response, first aid, decontamination and waste disposal
Training Requirements:
Mandatory SOP training and documentation for all users
Note:
Year
Topic:
HIV Diagnosis, Linkage to Care, and Prevention Services
Document Type:
Guide
Organization / Institution:
CDC
Target Audience:
HIV-positive individuals who participated in the GAIN study
Year:
N/A
Region / City:
N/A
Topic:
HIV Diagnosis, HIV Prevention
Document Type:
Survey
Organization / Institution:
CDC
Author:
N/A
Target Audience:
Participants of the GAIN Study
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region:
Not specified
Document type:
Supplementary material / Research data
Methods:
LC-MS/MS, IP–HILIC–MS/MS
Analytes:
Tenofovir (TFV), Tenofovir-diphosphate (TFV-DP)
Sample types:
Urine, Dried Blood Spots (DBS)
Target population:
Participants on antiretroviral therapy (ART)
Measured variables:
Urine TFV concentration, DBS TFV-DP concentration, POC TFV results, self-reported adherence, viral load, drug resistance
Instrument:
Agilent HPLC coupled to AB Sciex 5500 triple quadrupole mass spectrometer
Software:
Analyst v1.6.2
Detection method:
Negative-ion multiple reaction monitoring (MRM)
Tables included:
S1, S2, S3, S4
Year:
2013
Region / City:
International
Subject:
Veterinary clinical pathology; Point-of-care testing quality assurance
Document Type:
Guideline / Compliance checklist
Organization:
American Society for Veterinary Clinical Pathology (ASVCP)
Authors:
Bente Flatland, Kathleen P. Freeman, Linda M. Vap, Kendal E. Harr
Target Audience:
Veterinary laboratories, clinical pathologists, veterinary diagnostic personnel
Version:
1.0
Date of Publication:
May 2013
Reference Links:
www.asvcp.org
Institution:
Xi’an Jiaotong-Liverpool University, China
School:
School of Advanced Technology
Project Title:
Paper-based microfluidic devices for point-of-care disease diagnosis 全自动、快速微流控纸基生物传感器的研究与开发
Supervisors:
Dr. Pengfei Song (Principal Supervisor, XJTLU); Dr. Chunfeng Yue (JITRI); Dr. Kai Hoettges (University of Liverpool)
Degree Awarding Body:
University of Liverpool, United Kingdom
Funding Type:
Funded PhD project
Funding Coverage:
Tuition fees for three years (RMB 80,000 per annum) and monthly living allowance of RMB 3000 during research at Micro-Nano Automation Institute
Duration:
Three years (subject to satisfactory progress)
Application Deadline:
Open until the position is filled
Location of Research:
Suzhou, China
Collaborating Institutions:
XJTLU and Jiangsu Industrial Technology Research Institute (Micro-Nano Automation Institute)
Research Field:
Paper-based microfluidics; point-of-care diagnostics; biomedical engineering
Project Focus:
Development of automated μPAD platform for rapid detection of COVID-19 and influenza antigen markers
Eligibility Criteria:
First class or upper second class honours degree or master’s degree in relevant engineering disciplines
English Language Requirement:
IELTS 6.5 or above (if first language is not English)
Application Materials:
CV; two reference letters; personal statement; proof of English proficiency; verified transcripts and certificates; Master’s dissertation or equivalent writing sample
Version:
1.0
Circulated date:
January 2024
Review date:
July 2024
Scope:
Children and young people with Type 1 diabetes (CYP with T1DM)
Guideline reference:
NICE NG18 (2022)
Type:
Implementation document
Region:
London
Target audience:
Paediatric diabetes teams, healthcare professionals, CYP with T1DM and their families
Components:
Written pathway, implementation flowchart, accompanying device list
Device focus:
Continuous glucose monitoring (CGM)
Purpose:
Support implementation of NG18 and guide device choice
Year:
2023
Region / city:
United States, Abu Dhabi, Cambridge, Riyadh, Detroit, Brooklyn, Los Angeles
Theme:
Health, Diabetes, Mortality, Cardiovascular Disease
Document Type:
Research Article
Organization / Institution:
Drexel University, NYU Lutheran Medical Center, University of California San Francisco, University of Cambridge, King Faisal Specialist Hospital, Wayne State University
Author:
Sunil E. Saith, MD, Andrew Kohut, MD, MPH, Jun Tang, Ph.D, Greg Irving, MBBS, Shamma A. Al Memari, MBBS, Afra D. Al Dhaheri, MBBS, Fatimah S. Alhamlan, Ph.D, Mahdi Shkoukani, MD
Target Audience:
Medical researchers, healthcare professionals, clinicians
Period of Effect:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Abstract:
To assess if high-normal random blood glucose (RBG) levels correlate with higher all-cause mortality risk compared to normal RBG levels.
Introduction:
Investigates the relationship between high-normal blood glucose levels and increased mortality risk.
Year:
2024
Region / City:
United States
Topic:
Health, Diabetes Management
Document Type:
Addendum, Medical Form
Organization / Institution:
Diabetes Resource Nurses of Colorado, Inc.
Author:
Diabetes Resource Nurses of Colorado, Inc.
Target Audience:
School Nurses, Parents, Healthcare Providers
Approval Date:
September 2024
Date of Changes:
September 2024
Note:
Year
Region / City:
North Central London
Topic:
Continuous Glucose Monitoring (CGM)
Document Type:
Information Document
Organization:
NHS
Target Audience:
General Practices in North Central London
Year:
2023
Region / city:
North East London
Topic:
Healthcare, Diabetes, Continuous Glucose Monitoring
Document Type:
Medical Guidance
Organization:
Barts Health NHS Trust, Homerton Healthcare NHS Foundation Trust, Barking, Havering and Redbridge University Hospitals NHS Trust
Author:
Specialist diabetes teams
Target Audience:
Healthcare professionals, primary care physicians
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
August 2023
Note:
Context description
Year:
2023
Region / City:
Not specified
Topic:
Tumor Metabolism, Glycolysis, Kinetic Modeling
Document Type:
Research Paper
Institution / Organization:
Not specified
Author:
JHGM van Beek
Target Audience:
Researchers in biochemistry and oncology
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Title:
Supplementary Material 1: KAP Questionnaire for Glucose Management
Document type:
Questionnaire
Subject:
Glucose management in critically ill patients
Structure:
Knowledge dimension; Attitude dimension; Practice dimension
Target population:
ICU nurses
Clinical focus:
Glycemic control, insulin therapy, hypoglycemia and hyperglycemia management
Measurement units:
mmol/L; U/ml
Setting:
Intensive care unit
Reference:
Specialist service referral to GP
Document type:
Clinical recommendation letter
Subject:
Prescription of isCGM or rtCGM device
Related conditions:
Type 1 diabetes; Type 2 diabetes
Guidance referenced:
NICE NG17; NICE NG18; NICE NG28
Regional policy:
Cheshire and Merseyside Area Prescribing Group recommendation
Device category:
Intermittently scanned continuous glucose monitoring (isCGM); Real time continuous glucose monitoring (rtCGM)
Intended recipient:
General Practitioner
Patient status:
Counselled and informed regarding device use and access
Clinical context:
Green status for adults; Amber Recommended for children with type 1 diabetes and eligible people with type 2 diabetes
Year:
2023
Region / City:
Fukuoka, Japan
Topic:
Medical / Health
Document Type:
Research Article
Author:
Hitomi Miyazaki, Masumi Nagae, Hiroshi Uchida, Kuniyoshi Shimizu
Target Audience:
Medical professionals, researchers
Approval Date:
December 8th, 2023
Study Participants:
18 healthy adult men and women
Ethics Approval:
Yes
Conflicts of Interest:
None
Publication Fee:
$1,595.00
Journal:
Functional Foods in Health and Disease
Co-author Contact:
Masumi Nagae, Hiroshi Uchida, Kuniyoshi Shimizu
Peer Reviewers:
Masaki Taga, Hiroaki Masuzaki, Toshio Hosaka, Mei Hui Liu, Anne Nilsson
Organization:
POCT Pathology Department
Role:
POCT Coordinator
Contact Telephone:
07500050655
Contact Email:
[email protected]
Subject:
Glucose and Ketone Quality Control Procedure
Device:
FPP Meter
Testing Types:
Glucose Testing, Ketone Testing
Procedure Type:
Quality Control Instruction
Intended Users:
Clinical Staff Operating FPP Meter
Document Purpose:
Operational Guidance
Population:
Paediatric patients in cardiac arrest suspected to be caused by hyperkalaemia
Intervention:
Insulin with glucose or salbutamol
Comparison:
No insulin with glucose and no salbutamol
Main outcomes:
Survival to discharge; Survival to discharge with favourable neurological outcome (PCPC 1–3 or no change from baseline); Survival to discharge with PCPC 1–2 or no change from baseline
Setting:
Any setting
Perspective:
Not specified
Conflict of interests:
None
Problem priority:
Varies
Desirable effects:
Small
Undesirable effects:
Trivial
Certainty of evidence:
No included studies
Values and preferences:
Probably no important uncertainty or variability
Balance of effects:
Probably favors the intervention
Resources required:
Varies
Certainty of evidence of required resources:
No included studies
Cost effectiveness:
No included studies
Equity impact:
Unknown
Acceptability:
Unknown
Feasibility:
Probably yes
Year:
2026
Region:
Laboratory Study
Subject:
Blood Glucose Measurement
Document Type:
Research Data Report
Institution:
University or Research Laboratory
Author:
Not specified
Target Audience:
Biomedical researchers
Study Period:
Post-induction observation
Date of Data Collection:
Not specified
Test Methods:
Descriptive statistics, Normality tests, ANOVA, Kruskal-Wallis, Post-hoc LSD
Variables Measured:
GDP_Pre, GDP_Post, VAR00001, VAR00005
Experimental Groups:
K-, K+, P1, P2
Sample Size:
15 subjects across 4 groups
Statistical Software:
Not specified
Data Distribution Analysis:
Lilliefors correction, Shapiro-Wilk test
Variance Homogeneity Tests:
Levene, Robust equality tests
Significance Threshold:
0.05
Analysis Focus:
Differences in blood glucose levels between experimental groups
Year:
2016
Region / Institution:
Hull & East Yorkshire NHS Hospitals Trust, UK
Topic:
Diabetes management, glucose monitoring
Document type:
Clinical guidance summary
Author:
Dr Jane Patmore
Target audience:
Healthcare professionals, patients with Type 1 diabetes
Guideline source:
NICE NG17
Device discussed:
Freestyle Libre flash glucose monitoring system
Patient criteria:
Severe hypoglycaemia, hypoglycaemia unawareness, frequent asymptomatic hypoglycaemia, extreme fear of hypoglycaemia, persistent hyperglycaemia, recurrent DKA
Study references:
JDRF CGM study, ABCD position statement, American Diabetes Association 2016 abstract
Data presentation:
Ambulatory Glucose Profile (AGP)
Implementation setting:
Clinical and home use for patient monitoring
Outcome focus:
Reduction of hypoglycaemia, improved glycaemic control, hospital admission reduction
Year:
2019-2022
Region / City:
Israel
Topic:
Continuous Glucose Monitoring, Non-Diabetic Population
Document Type:
Research Article
Institution:
Weizmann Institute of Science, Tel Aviv University, Rabin Medical Center, Pheno.AI
Authors:
Ayya Keshet, Smadar Shilo, Anastasia Godneva, Yeela Talmor-Barkan, Yaron Aviv, Eran Segal, Hagai Rossman
Target Audience:
Researchers, Clinicians
Study Population:
7,104 non-diabetic adults, aged 40-70, 45.7% male, 54.3% female
Methodology:
Continuous Glucose Monitoring, blood tests, DXA scans, food intake logging, sleep monitoring
Key Measurements:
Mean blood glucose, glucose variability, clinical measures related to cardiovascular health, nutrition, and sleep
Lead Contact:
Dr. Hagai Rossman
Corresponding Author:
Prof. Eran Segal
Purpose:
Establish reference values for CGM-derived metrics in a healthy population